Product Categories
| Country: | China |
|---|---|
| Tel: | +86-16588669988 |
| Mobile: | +86-16588669988 |
| E-mail: | ryan.shao@pipharma.com.cn |
| QQ: | |
| Skype: | Chat Now! |
| Address: | No.20 Building, Area A ,Park Street South, Industry & Trade Road West Industrial Park, Shuangtaizi District |
|
Liaoning Pharmaceutical Innovation Co., Ltd registered on September 16th, 2021, with a registered capital of 12 million RMB, is located in Chemical Industrial District, Panjin, Liaoning. It is a company engaged in the research, development, and production of active pharmaceutical ingredients and intermediates.
The company is a subsidiary of Tianjin Pharmaceutical Innovation Co., Ltd. Tianjin P&I was established in July 2009 and is located in the Tianjin Binhai Development District. It is a high-tech enterprise specializing in the research, development, and production of active pharmaceutical ingredients and intermediates and providing pharmaceutical research and development outsourcing services.
The company has a research and development center, a pilot workshop, and a GMP production base. It integrates research, pilot testing, and production, dedicated to providing high-quality pharmaceutical chemicals and contract manufacturing services to pharmaceutical companies worldwide. As a research-oriented and customer-centrist enterprise, it consistently strives to improve its technical innovation system. It prioritizes scientific and technological innovation, utilizes advanced and comprehensive production facilities, and has a robust quality assurance system to ensure the safe production of high-quality products. The company's progressive and innovative mindset, dedicated employees, and reasonable resource allocation are the solid foundation for the continuous development and growth of P&I.
The company's main business covers various regions around the world. P&I has 47 patents, including six invention patents, all of which have been granted. Tianjin P&I is recognized as a national high-tech enterprise. After more than a decade of development, it has established a production system spanning small-scale research and development to pilot and industrial-scale mass production. It has also found improved process technology research for active pharmaceutical ingredients,
|
|
| Product Name | MF | CAS | Details |
|---|
| Dehydronandrolon | C20H26O3 | 2590-41-2 | Details |
| Fulvestrant intermediate | C34H51F5O3S | 415927-29-6 | Details |
| Fulvestrant intermediate | C36H51F5O4S | 1428484-17-6 | Details |
| Fulvestrant intermediate | C30H46O6S | 1610351-44-4 | Details |
| Fulvestrant intermediate | C27H41BrO2 | 875573-67-4 | Details |
| Fulvestrant intermediate | C29H43BrO3 | 875573-66-3 | Details |
| Fulvestrant intermediate | C14H24BrF5S | 148757-89-5 | Details |
| Trilostane | C20H27NO3 | 13647-35-3 | Details |
| TrilostaneN-1 | C20H27NO3 | 20051-76-7 | Details |
| pimobendan | C19H18N4O2 | 74150-27-9 | Details |
| Dexmedetomidine hydrochloride | C13H17ClN2 | 145108-58-3 | Details |
| Romifidine Hydrochloride, Monohydrochloride | C9H10BrClFN3 | 65896-14-2 | Details |
| Milbemycin Oxime | 2C32H45NO7.2C31H43NO7 | 129496-10-2 | Details |
| Febantel | C20H22N4O6S | 58306-30-2 | Details |
| Gestrinone | C21H24O2 | 16320-04-0 | Details |
| Denazacort | C25H31NO6 | 14484-47-0 | Details |
| Firocoxib | C17H20O5S | 189954-96-9 | Details |
| Ivermectin | C19H34O3 | 65733-16-6 | Details |
| Paracetamol | C8H9NO2 | 103-90-2 | Details |
| Famotidine | C8H15N7O2S3 | 76824-35-6 | Details |
| Benorilate | C17H15NO5 | 5003-48-5 | Details |
| Fenbufen | C16H14O3 | 36330-85-5 | Details |
| Benproperine Phosphate | C21H30NO5P | 19428-14-9 | Details |
| Diclofenac Sodium | C14H10Cl2NNaO2 | 15307-79-6 | Details |
| Proglumide | C18H26N2O4 | 6620-60-6 | Details |
| Troxerutin | C33H42O19 | 7085-55-4 | Details |
| Moroxydine Hydrochloride | C6H14ClN5O | 3160-91-6 | Details |
| Furazolidone | C8H7N3O5 | 67-45-8 | Details |
| cloperastine hydrochloride | C20H25Cl2NO | 14984-68-0 | Details |
| Dioxopromethazine HCl | C17H20N2O2S | 13754-56-8 | Details |
| Furosemide | C12H11ClN2O5S | 54-31-9 | Details |
| norfloxacin hydrochloride | C16H18FN3O3 | 70458-96-7 | Details |
| Nifedipine | C17H18N2O6 | 21829-25-4 | Details |
| Nefopan Hydrochloride | C17H20ClNO | 23327-57-3 | Details |
| Piroxicam | C15H13N3O4S | 36322-90-4 | Details |
| Diclazuril | C17H9Cl3N4O2 | 101831-37-2 | Details |
| Ivermectin | C48H74O14 | 70288-86-7 | Details |
| albendazole | C15H13N3O2S | 43210-67-9 | Details |
| Levomisole HCl | C11H13ClN2S | 16595-80-5 | Details |
| Enrofloxacin | C22H25ClN2O9 | 2058-46-0 | Details |
| enrofloxacin HCL | C19H23ClFN3O3 | 112732-17-9 | Details |
| trimethoprim | C14H18N4O3 | 738-70-5 | Details |
| Praziquantel | C19H24N2O2 | 55268-74-1 | Details |
| amprolium hydrochloride | C14H20Cl2N4 | 137-88-2 | Details |
| robenidine hydrochloride | C15H14Cl3N5 | 25875-50-7 | Details |
| rafoxanide | C19H11Cl2I2NO3 | 22662-39-1 | Details |
| tetramisole hydrochloride | C11H13ClN2S | 5086-74-8 | Details |
| Ciprofloxacin Hydrochloride | C17H18FN3O3.HCl | 93107-08-5 | Details |
| Ciprofloxacin Lactate | C20H24FN3O6 | 97867-33-9 | Details |
| pefloxacin mesylate | C16H18FN3O3.HCl | 104142-93-0 | Details |
| ofloxacin | C18H20FN3O4 | 82419-36-1 | Details |
| Levofloxacin Hemihydrate | C18H22FN3O5 | 138199-71-0 | Details |
| sarafloxacin hydrochloride | C20H17F2N3O3 | 98105-99-8 | Details |
| sulfadiazine | C10H10N4O2S | 68-35-9 | Details |
| Sulfadiazine Sodium | C10H11N4NaO2S | 547-32-0 | Details |
| trimethoprim lactate | C17H24N4O6 | 23256-42-0 | Details |
| diverdine hcl | C13H16N4O2.ClH | 2507-23-5 | Details |
| sulfachlorpyrazine | C10H9ClN4O2S | 102-65-8 | Details |
| Sulfachloropyridazine sodium | C10H10ClN4NaO2S | 23282-55-5 | Details |
| Sulfamethoxazole | C10H11N3O3S | 723-46-6 | Details |
| sodium sulfaquinoxaline | C14H13N4NaO2S | 967-80-6 | Details |
| sulphaguanidine | C7H10N4O2S | 57-67-0 | Details |
| (2R)-4-BENZYL-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}MORPHOLIN-3-ONE | C21H19F6NO3 | 287930-75-0 | Details |
| Phenacetin | C10H13NO2 | 62-44-2 | Details |
| Tilmicosin | C46H80N2O13 | 108050-54-0 | Details |
| Tilmicosin phosphate | C46H83N2O17P | 137330-13-3 | Details |
| Doxycycline Hyclate | C24H31ClN2O9 | 24390-14-5 | Details |
| rifampicin | C43H58N4O12 | 13292-46-1 | Details |
| isoniazide | C6H7N3O | 54-85-3 | Details |
| gentamycin sulphate | C60H127N15O26S | 1405-41-0 | Details |
| Tylosin tartrate | C46H77NO17.C4H6O6 | 74610-55-2 | Details |
| Colistin sulfate | 2(C52H98N16O13).5(H2SO4) | 1264-72-8 | Details |
| Tiamulin Fumarate | C32H51NO8S | 55297-96-6 | Details |
| metronidazole | C6H9N3O3 | 443-48-1 | Details |
| Aspirin | C9H8O4 | 50-78-2 | Details |
| Amikacin Sulfate | C22H45N5O17S | 39831-55-5 | Details |
| Lincomycin HCl | C18H35ClN2O6S | 859-18-7 | Details |
| clindamycin hydrochloride | C18H34Cl2N2O5S | 21462-39-5 | Details |
| Spectinomycin Sulfate | C14H26N2O11S | 64058-48-6 | Details |
| spectinomycin hydrochloride | C14H25ClN2O7 | 21736-83-4 | Details |
| estradiol benzoate | C25H28O3 | 50-50-0 | Details |
| dexamethasone acetate | C24H31FO6 | 1177-87-3 | Details |
| Ceftiofur sodium | C19H18N5NaO7S3 | 104010-37-9 | Details |
| Ceftiofur HCL | C19H18ClN5O7S3 | 103980-44-5 | Details |
| dexamethasone sodium phosphate | C22H28FNa2O8P | 55203-24-2 | Details |
| Amoxicillin sodium | C16H20N3NaO5S | 34642-77-8 | Details |
| thiamphenicol | C12H15Cl2NO5S | 15318-45-3 | Details |
| kitasamycin tartrate | C40H67NO18 | 37280-56-1 | Details |
| kitasamycin | C35H59NO13 | 1392-21-8 | Details |
| florfenicol | C12H14Cl2FNO4S | 73231-34-2 | Details |
| tetracycline hydrochloride | C22H25ClN2O8 | 64-75-5 | Details |
| Neomycin sulfate | C23H48N6O17S | 1405-10-3 | Details |
| Fulvestrant intermediate | C32H47F5O2S | 153004-31-0 | Details |
| Atipamezole hydrochloride | C14H16N2.HCl | 104075-48-1 | Details |
| Fipronil | C12H4Cl2F6N4OS | 120068-37-3 | Details |
| Fulvestrant | C32H47F5O3S | 129453-61-8 | Details |
| Procaine Hydrochloride | C13H21ClN2O2 | 51-05-8 | Details |
| Ketoprofen | C16H14O3 | 22071-15-4 | Details |
| Diphenhydramine Hydrochloride | C17H22ClNO | 147-24-0 | Details |
| Afoxolaner | C26H17ClF9N3O3 | 1093861-60-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||